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The degradation of the aromatic compound phenylpropi-
onate (PP) inEscherichia coliK-12 requires the activation of two
different catabolic pathways coded by the hca and themhp gene
clusters involved in themineralization of PP and 3-hydroxyphe-
nylpropionate (3HPP), respectively. The compound 3-(2,3-di-
hydroxyphenyl)propionate (DHPP) is a common intermediate
of both pathways which must be cleaved by the MhpB dioxyge-
nase before entering into the primary cell metabolism. There-
fore, the degradation of PP has to be controlled by both its spe-
cific regulator (HcaR) but also by theMhpR regulator of themhp
cluster. We have demonstrated that 3HPP and DHPP are the
true and best activators of MhpR, whereas PP only induces no
response. However, in vivo and in vitro transcription experi-
ments have demonstrated that PP activates theMhpR regulator
synergistically with the true inducers, representing the first case
of such a peculiar synergistic effect described for a bacterial reg-
ulator. The three compounds enhanced the interaction ofMhpR
with its DNA operator in electrophoretic mobility shift assays.
Inducer binding to MhpR is detected by circular dichroism and
fluorescence spectroscopies. Fluorescence quenching measure-
ments have revealed that the true inducers (3HPP and DHPP)
and PP bind with similar affinities and independently toMhpR.
This type of dual-metabolite synergy provides great potential
for a rapid modulation of gene expression and represents an
important feature of transcriptional control. The mhp regula-
tory system is an example of the high complexity achievable in
prokaryotes.
Phenylpropanoic and phenylpropenoic acids and their
hydroxylated derivatives are widely distributed in the environ-
ment, arising from digestion of aromatic amino acids or as
breakdown products of lignin and other plant-derived phenyl-
propanoids and flavonoids. The bacterial catabolism of these
aromatic compounds plays a key role in recycling of such car-
bon sources in the ecosystem (1, 2). Most Escherichia coli
strains are able to degrade these compounds via ameta-fission
pathway (3). A scheme of the biochemical pathway for the
catabolism of 3-hydroxyphenylpropionate (3HPP)2 and 3-hy-
doxycinnamate (3HCI) in E. coli K-12 is shown in Fig. 1B. The
first step is catalyzed by the MhpA hydroxylase, which inserts
one atom of molecular oxygen at the position 2 of the phenyl
ring of 3HPP to give 3-(2,3-dihydroxyphenyl)propionic acid
(DHPP). This intermediate is then converted to succinate,
pyruvate, and acetyl-CoA through the action of a meta-cleav-
age hydrolytic route whose enzymes are encoded by the mhp
cluster located at minute 8.0 of the genome (Fig. 1A), being the
first hydroxyphenylpropionate degradation pathway described
both at the biochemical and genetic levels (3–6). Themhp clus-
ter is arranged as follows: (i) six catabolic genes encoding the
initial monooxygenase (mhpA), the extradiol dioxygenase
(mhpB), and the hydrolytic meta-cleavage enzymes (mhpC-
DFE); (ii) a gene (mhpT) that encodes a potential transporter; (iii)
a regulatory gene (mhpR) which is adjacent to the catabolic genes
but transcribed in the opposite direction (5). Promoters Pr and Pa
control the expression of the divergently transcribedmhpR regu-
latory gene andmhp catabolic genes, respectively (Fig. 1A).
Remarkably, the catabolism of 3HPP is connected with deg-
radation of phenylpropionic acid (PP) through the common
intermediate DHPP (6). The hca cluster encoding the enzymes
responsible for the early steps of PP catabolism is located at
minute 57.5 of the genome and contains (i) five genes encoding
PP-dioxygenase (hcaEFCD; formerly named as hcaA1A2CD)
and PP-dihydrodiol dehydrogenase (hcaB), (ii) a regulatory
gene (hcaR), and (iii) a gene (hcaT) that might encode a trans-
porter. The genes hcaR and hcaT are transcribed in the oppo-
site direction from the other genes of cluster (Fig. 1A). The first
biochemical step of PP degradation is catalyzed by a PP dioxy-
genase (HcaA1A2CD), which adds oxygen atoms to positions 2
and 3 of the PP phenyl ring and is subsequently oxidized by the
HcaB dehydrogenase to give DHPP (Fig. 1B). Therefore, this
compound links the catabolism of PP and 3HPP in E. coli.
As mentioned above, the 3HPP and PP catabolic pathways
are regulated by two different regulatory proteins, MhpR and
HcaR, respectively. Expression ofmhp catabolic genes depends
on the transcriptional activator MhpR belonging to the IclR
family of transcriptional regulators (Fig. 1A) comprising more
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than 500 members identified from bacterial and Archaea
genomes. IclR regulators typically have an N-terminal helix-
turn-helix DNA binding motif and are linked by a long helix to
the effector binding domain (the best defining trait of the fam-
ily) located at the C-terminal domain. Sequence analysis of IclR
regulators revealed a very low conservation of the amino acids
residues involved in the effector binding, reflecting the chemi-
cal diversity of effector molecules recognized by the members
of this family. HcaR belongs to the LysR family of transcrip-
tional regulators and positively controls the neighboring genes,
hcaA1A2CBD, in the presence of PP and negatively controls its
own expression (Fig. 1A) (7, 8).
MhpR behaves as a 3HPP-depend-
ent activator of thePa catabolic pro-
moter by binding to its specific
operator sequence centered at posi-
tion 58 with respect to the tran-
scription start site in Pa promoter.
In contrast to HcaR,MhpR does not
autoregulate its own expression (9).
Expression of Pa promoter is also
influenced by the cAMP receptor
protein (CRP), which allows expres-
sion of the mhp catabolic genes
when the preferred carbon source
(glucose) is not available but 3HPP
is present in the medium (Fig. 1A).
MhpR shows a synergistic tran-
scription activation mechanism
with CRP (9).
Although transcriptional regula-
tors often respond to one molecule
which alters their binding to the
promoter region, it has been de-
scribed that in some particular
occasions multiple effectors can
regulate gene expression (10–12).
The combined effect of these com-
pounds on transcriptional control
by a single regulator is in general
poorly understood. Such combined
effects could play a relevant role in
those cases where two or more
pathways share common interme-
diates and must be synchronically
regulated, as appears to be the case
for the mhp and hca pathways. In
this work we have used different in
vivo and in vitro experimental
approaches to describe the synergis-
tic activation of MhpR in response
to different metabolites.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and
Growth Conditions—The E. coli
strains as well as the plasmids used
in this work are listed in Table 1.
Unless otherwise stated, bacteria were grown in Luria-Bertani
(LB) medium (16) at 37 °C. Growth in M63 minimal medium
(20) was achieved at 37 °C using the necessary nutritional sup-
plements and 20 mM glycerol as the carbon source. When
required, the appropriate amounts of aromatic compounds
were added to themedium.Antibiotics were used if indicated at
the following concentrations: ampicillin (100 g/ml), kanamy-
cin (50 g/ml), streptomycin (50 g/ml), spectinomycin (50
g/ml), and rifampicin (50 g/ml).
Plasmid DNAwas prepared with the High Pure Plasmid Iso-
lation Kit (Roche Applied Science). DNA fragments were puri-
FIGURE 1. Regulation and biochemistry of the mhp and hca clusters encoding the pathways for the
catabolism of 3HPP and PP, respectively, in E. coli. A, the organization of the catabolic (mhpABCDFE and
hcaA1A2CBD), transport (mhpT and hcaT), and regulatory (mhpR and hcaR) genes as well as their regulation by
MhpR and HcaR and the global regulator CRP are represented. The thick arrows indicate the direction of gene
transcription. Pr, Pa, and Pe are promoter regions. The black circle and the black trapezoid mean the inactive
forms of theMhpR activator and theHcaR activator, respectively; thewhite circle represents the inducer, and
indicates transcriptional activation. The double-headed arrow means synergistic transcription activation by
MhpR and CRP. B, scheme of the biochemistry of 3HPP and PP catabolic pathways. The 3HPP transport protein
(MhpT) is represented by a thick arrow. E and I indicate outside and inside the cell, respectively. A brief scheme
of the pathways including the final products and the first step for the transformation of 3HPP and PP into the
common intermediate DHPP by the action of the MhpAmonooxygenase and the HcaA1A2CD/HcaB dioxyge-
nase/dihydrodiol-dehydrogenase, respectively, is shown.
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fied with Gene-Clean Turbo (Q-BIOgene) and with High Pure
PCR Product Purification kit (Roche Applied Science). Oligo-
nucleotides were synthesized on an Oligo-1000 M nucleotide
synthesizer (Beckman Instruments). All the cloned inserts and
the DNA fragments were confirmed by DNA sequencing
through anABI Prism 377 automatedDNA sequencer (Applied
Biosystems Inc.). Transformation of E. coli cells was carried out
by using the RbCl method or by electroporation (Gene Pulser,
Bio-Rad) (16). Proteins were analyzed by SDS-PAGE as
described previously (21). The protein concentration of cell
extracts was determined by the method of Bradford (22) using
bovine serum albumin as standard.
By means of REP4-mediated mobilization, plasmid pUTAL2
(Table 1) containing the mini-Tn5Sm/Sp hybrid transposon
that expresses the Pa-lacZ fusion was transferred from E. coli
S17–1pir (Table 1) into kanamycin and streptomycin-resis-
tant E. coli ED1061 through biparental filter mating as
described previously (13). The reporter strains were selected
among three different candidates with similar expression levels
to avoid Pa unrelated lacZ expression rate caused by the posi-
tion of the insertion of the minitransposon. The relevant geno-
type of the resulting strain ED1061AL is indicated in Table 1.
Chemicals—DHPP, 2,3-dihydroxycinnamic acid, and 4-hy-
droxy-2-ketopentanoic acid were provided by T. Bugg from
University of Warwick, Coventry, UK. Phenylacetic acid (PA),
3-hydroxyphenylacetic acid (3HPA), 4-hydroxyphenylacetic
acid, cinnamic acid (CI), 3-methylphenylpropionic acid, and
phenol were purchased fromAldrich. Benzoic acid, 4-hydroxy-
benzoic acid, PP, 4-hydroxyphenylpropionic acid, 3HCI, 4-hy-
droxycinnamic acid, and indole were purchased from Sigma.
3HPP, 2-hydroxyphenylpropionic acid, 2-hydroxycinnamic
acid, 3-methylcinnamic acid, 3-methoxycinnamic acid, 3-chlo-
rocinnamic acid, 2-carboxycinnamic acid, 3-nitrocinnamic
acid, phenylbutyric acid, DL-meta-tyrosine, and 3-methoxyphe-
nylpropionic acid were purchased from Lancaster. 2-Hydroxy-
phenylacetic acid, 3-hydroxybenzoic acid, 4-fluorophenylac-
etic acid, and propylbenzene were acquired from Fluka.
L-phenylalanine was purchased fromMerck.
Overexpression and Purification of MhpR-His—Plasmid
pQMH was constructed by cloning into the double-digested
pQE32 plasmid a 850-bp BamHI/HindIII fragment harboring
themhpR gene that was PCR-amplified from the plasmid pPAL
(Table 1) by using oligonucleotidesMhpRhis5 (5- CGAGGA-
TCCCGCAGAACAATGAGCAGACGG-3; the engineered
BamHI site is underlined) and MhpRhis3 (5-CCCAAGCTT-
TCAACGTAAATGCATGCCGC-3; the engineeredHindIII is
underlined). The recombinant plasmid called pQMH (Table 1)
carries themhpR gene without the ATG start codon and with a
His6 tag coding sequence at its 5-end under control of the T5
promoter and two lac operator boxes. The His tail adds 13
amino acids (MRGSHHHHHHGIP) to the N-terminal end of
the MhpR protein (expected mass, 32,712 Da). The His-tagged
protein was overproduced in the E. coli M15 strain harboring
the plasmid pREP4 (Table 1), which produces the LacI repres-
sor to strictly control gene expression from pQE32 derivatives
in the presence of isopropyl-1-thio--D-galactopyranoside.
E. coliM15 (pREP4, pQMH) cells were grown at 37 °C in ampi-
cillin- and kanamycin-containing LBmediumuntil the cultures
reached an absorbance at 600 nm of A0.5. Overexpression of
MhpR-His was then induced for 4 h by the addition of 0.2 mM
isopropyl-1-thio--D-galactopyranoside. Cells were harvested,
resuspended in 40 ml of buffer A (50 mM NaH2PO4, 300 mM
NaCl, 100 mM imidazole, pH 8.0), and disrupted by passage
through a French press (Aminco Corp.) operated at a pressure
of 20,000 p.s.i. All purification steps were carried out at 4 °C.
The cell lysate was centrifuged at 20,000 g for 20min, and the
supernatant was ultracentrifuged at 150,000  g for 60 min.
Nucleic acids present in the supernatant were removed by pre-
cipitation with 2% streptomycin sulfate (Sigma) and stirred
gently for 60 min, and after centrifugation at 23,500 g for 20
min, the supernatant was dialyzed against buffer A and then
applied to a 5-ml nickel-nitrilotriacetic acid-agarose column
(Qiagen). The columnwaswashedwith 3 volumes of bufferA at
a flow rate of 0.5 ml/min. Elution of purifiedMhpR-His protein
was carried out with buffer B (50 mM NaH2PO4, 300 mM NaCl,
500 mM imidazole, pH 8.0) at a flow rate of 0.2 ml/min. The
purified protein was dialyzed against buffer C (100 mM Tris-
HCl, pH 7.5, 10% glycerol, and 500 mM KCl) and stored at
80 °C. Protein purity and molecular mass were confirmed by
SDS/PAGE.MhpR-His concentrationwas determined spectro-
photometrically by using themolar extinction coefficient at 280
nm ( 30,560 M1cm1) calculated on the basis of its amino
acid sequence.
-Galactosidase Assays—-Galactosidase activities were
measured with permeabilized cells as described by Miller (20).
Analytical Ultracentrifugation—Sedimentation velocity
experiments were performed at 20 °C with a Beckman Optima
XL-A analytical ultracentrifuge (Beckman Coulter) equipped
with UV-visible absorbance optics and using double sector
Epon-charcoal centerpieces. Concentration gradients were
monitored at 200,000  g by measuring sample absorbance at
280 nm for detection of the concentration gradient. Measure-
ments were performed at 15 M MhpR-His in the absence and
presence of 400 and 800 M 3HPP. Differential sedimentation
coefficients, c(s), were calculated by least-squares boundary
modeling sedimentation velocity data using the program
SEDFIT (23, 24). The sedimentation coefficients were corrected
for buffer composition using the program SEDNTERP (25) to
get the corresponding standard values (water and 20 °C).
Gel Retardation Assays (Electrophoretic Mobility Shift
Assays)—The DNA fragment Pa-Pr used as a probe was
amplified by PCR using 10 ng of plasmid pRAL (Table 1) as a
template and the oligonucleotides PP6 (5-CCGTCTGCTC-
ATTGTTCTG-3) and LAC57 (5-CGATTAAGTTGGGTA-
ACGCCAGGG-3). The DNA fragment was labeled at its
5-end using the phage T4 DNA polynucleotide kinase (10
units/l) (Biolabs) and [-32P]ATP (3000 Ci/mmol) (Amer-
sham Biosciences). The fragment (274 bp) was purified on a
glass fiber column (High Pure PCR purification kit, Roche
Applied Science). The reactionmixtures contained 30mMTris-
HCl, pH 7.5, 100 mM KCl, 2 mM -mercaptoethanol, 10% glyc-
erol, 1 nM DNA probe, 50 g/ml bovine serum albumin, 50
g/ml salmon sperm (competitor) DNA, and purified MhpR-
His in a 10-l final volume.After incubation at 25 °C for 15min,
mixtures were loaded into 4% native polyacrylamide gel with
buffer 0.5TBE (45mMTris borate pH 8.3, 1 mM EDTA). The
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gels were dried ontoWhatmanNo. 3MMpaper and exposed to
Hyperfilm MP (Amersham Biosciences).
In Vitro Transcription Assays—Single-round transcription
by E. coli RNApwas carried out under standard conditions (18)
using as reaction buffer 40 mM Tris-HCl, pH 7.5, containing 10
mM MgCl2, 100 mM KCl, 200 M cAMP, and 500 g/ml acety-
lated bovine serum albumin. Plasmid pJCDAR was used as a
DNA template. To construct this plasmid, the oligonucleotides
PaPr5 (5-CGCGAATTCCGGTTTTGTATTCCGTCTGC-
3) and PaPr3 (CGCGGATCCCATTTCAGTACCTCACGA-
CTC-3) were used for PCR amplification of themhpR-mhpA
intergenic region using the plasmid pRAL as DNA template,
and the resulting fragment was cloned into the plasmid
pJCD01 which contains the pUC19 polylinker between
EcoRI and PstI sites flanked by the divergent terminators
rpoCT and rrnBT1T2, respectively (Table 1). The reaction
mixtures (9 l) contained the plasmid DNA (5 nM) with CRP
(200 nM) and MhpR (100 nM) or buffer. When required the
effector molecules were also added, and the mixture was incu-
bated at 25 °C for 20 min. Finally, 3 l of RNAp (Epicenter) at
375 nM were added, and the mixture was incubated at 37 °C for
5 min in a final volume of 12 l. Elongation was started by the
addition of 3l of a prewarmedmixture containing 1mMATP,
1 mM GTP, 1 mM CTP, 50 M UTP, 1 Ci of [-32P]UTP and
500g/ml heparin in the same buffer to the template-polymer-
asemix, and the reaction was allowed to proceed for 15 min at
37 °C. Reaction was stopped by the addition of 10 l of load-
ing buffer containing 1% SDS. After heating at 70 °C, samples
were subjected to electrophoresis on 6% sequencing gels,
and run-off products were quantified using a Quantity One
program (Bio-Rad).
Circular Dichroism (CD) Spectroscopy—Circular dichroism
measurements were made with a Jasco J-715 spectropolarime-
ter using 0.1-cm path length quartz cuvettes. CD spectra were
acquired at 20 °C in 20 mM potassium phosphate, 100 mM KCl
buffer, pH 7.5, using a protein concentration of 6.5 M (1-nm
bandwidth, 4-s response, and 20-nm/min scan speed). Five
spectra were averaged for each sample, and the spectrum of the
buffer was subtracted. Thermal denaturation studies were per-
formed with the same samples, overlaid with mineral oil. The
CD signal at 220 nm was measured as the temperature was
increased from 5 to 90 °C at 50 °C/h using a Peltier temperature
control accessory. The content of secondary structure was esti-
mated by analyzing the far-UVCD spectra using three different
programs: CONTIN, which implements the ridge regression
algorithm of Provencher and Glo¨ckner (26); SELCON, which
incorporates a self-consistent method together with the singu-
lar value decomposition algorithm to assign protein secondary
structure (27), and CDNN based on the use of neural networks
(28).
Fluorescence Measurements of Ligand Binding to MhpR-His—
Fluorescence spectra of MhpR-His were acquired at 25 °C
employing a Fluorolog spectrofluorometer with a 5-mm (exci-
tation) 10-mm (emission) quartz cuvette, withmagnetic stir-
ring to reduce photolysis. Tryptophan residues in the protein
were selectively excited at 295 nm (1-nm bandwidth), and the
emission was scanned from 305 to 400 nm (5-nm bandwidth).
Samples of MhpR-His were diluted to a final concentration of
500 nM in 20 mM Tris-HCl, 100 mM KCl, pH 7.5, and a maxi-
mum volume of 10 l ligand solution (prepared in the same
buffer) was added to the protein solution to achieve final ligand
concentrations in the range of 10–100 M (1 ml total reaction
volume). To avoid inner filter effects, the absorbance of ligand
solutions at 295 and 340 nm was kept below 0.02 and 0.005,
respectively. All measurements were corrected for the back-
ground emission of the buffer, free ligand solutions, and
dilution.
Quenching of protein fluorescence by ligand binding was
analyzed with the single-site binding model, employing the fol-
lowing expression,
F  1  1  FminKbligand	free/1	 Kbligand	free (Eq. 1)
where F is the fluorescence intensity at 335 nm (relative to the
intensity in the absence of ligand), Kb  Kd1 is the binding
equilibrium constant, and Fmin is the minimal relative fluores-
cence ligand saturating conditions. Equation 1 was fitted to the
data employing the Sigmaplot software to obtain the best-fit-
ting binding parameters. Given the large excess of ligand over
protein concentration, the total ligand concentration was to a
good approximation equal to the free ligand concentration.
RESULTS
Effector Specificity of the MhpR Regulator—Previous studies
showed that 3HPP and 3HCI, the natural substrates of themhp
pathway, induced the expression of the catabolic genes driven
by the Pa promoter (8). To investigate other potential effectors
of MhpR using lacZ as a reporter gene, we cultured the strain
E. coliAFMCRAL (Table 1) in the presence of a large collection
of aromatic compounds. The parental strainMC4100 is unable
to transform 3HPP into DHPP because it contains a chromo-
somal deletion spanning the entire lac operon and the first
genes of themhp cluster (29). Fig. 2A shows that 3HPP, DHPP,
and PP are the best inducers molecules of MhpR. Concerning
the effect of PP, it is important to take into account that PP can
be transformed in vivo into DHPP through the hca cluster con-
tained in this strain. Furthermore, we observed that the other
substrate of the mhp pathway, 3HCI, induces MhpR 2.5-fold
less than 3HPP, whereas its derivative, 2,3-dihydroxycinnamic
acid, does not induce the Pa promoter. These results suggest
that the presence of a hydroxyl group at positions 2 or 3 of the
PP aromatic ring is necessary forMhpR recognition. Neverthe-
less, the induction by 2-hydroxyphenylpropionic acid is 20-fold
lower than by 3HPP, and 2-hydroxycinnamic acid is not an
effector of MhpR. Moreover, the hydroxylated derivates at
position 4, 4-hydroxyphenylpropionic acid and 4-hydroxycin-
namic acid, are not inducers. In addition, the substitution of the
hydroxyl group at position 3 of the aromatic ring of PP or CI by
methyl (3-methylphenylpropionic acid; 3-methylcinnamic
acid), methoxy (3-methoxyphenylpropionic acid; 3-methoxy-
cinnamic acid), chloro (3-chlorocinnamic acid), or nitro (3-ni-
trocinnamic acid) groups did not allow the expression of mhp
genes. Finally, the compound 2-carboxycinnamic acid does not
act as an effector molecule. As mentioned above, the inducer
DHPP is an intermediate metabolite also produced during the
PP degradation (Fig. 1B). Therefore, it was necessary to deter-
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mine whether the activation of Pa promoter by PP observed in
E. coli AFMCRAL was because of the DHPP derived from PP, or
the effect was because of a PP direct activation. To this end, -ga-
lactosidase assays were performed
using E. coli ED1061AL (pPAL)
(Table 1). This is a mutant strain
that carries a chromosomal disrup-
tion of the hcaA1 gene (8) harboring
Pa::lacZ fusion in the chromosome
(Table 1). This mutant strain does
not transform PP into DHPP, and
thus, the putative effect of PP can
be tested without interferences.
Remarkably, Fig. 2B shows that
under these circumstances -galac-
tosidase activity was not detected in
the presence of PP, demonstrating
that it is not a real inducer of the
mhp pathway.
In Vivo Modulation of MhpR
Activity by PP—Because degrada-
tion of PP in E. coli requires the
induction of themhp genes (Fig. 1),
it could be anticipated that PPmight
also modulate the activity of the
MhpR regulator that controls the
expression of the mhp genes. To
investigate the putative PP effect, we
monitored the activity of Pa pro-
moter in E. coli ED1061AL (pPAL)
(Table 1). Cells were grown in LB
medium in the presence of increas-
ing concentrations of 3HPP and
with or without 1 mM PP. Interest-
ingly, the addition of PP increased
the activity of MhpR; although
it was not system-induced, we
observed an additive effect that
increased the activity of MhpR (Fig. 3A). This synergistic effect
of PPwas also observedwhen 3HPPwas replaced in the assay by
FIGURE 2. Inducer profile of mhp genes. A, E. coli AFMCRAL (mhpR/Pa-lacZ) was grown in LB medium in the
presence of 1 mM concentrations of the tested compounds until the cultures reached an A600 of 0.8–1.0. 2HPP,
2-hydroxyphenylpropionicacid;3HCI, 3-hydroxycinnamicacid;DHCI, 2,3-dihydroxycinnamicacid;4HPP, 4-hydroxy-
phenylpropionic acid; 3-methyl-PP, 3-methylphenylpropionic acid; 3-methoxy-PP, 3-methoxyphenylpropionic acid;
CI, cinnamic acid; 4HCI, 4-hydroxycinnamic acid; 2HCI, 2-hydroxycinnamic acid; 3NCI, 3-nitrocinnamic acid; 3CLCI,
3-chlorocinnamic acid; 3-methyl-CI, 3-methylcinnamic acid; 3-methoxy-CI, 3-methoxycinnamic acid; 2-carboxy-CI,
2-carboxycinnamic acid; 2HPA, 2-hydroxyphenylacetic acid; 3HPA, 3-hydroxyphenylacetic acid; 4HPA, 4-hydroxy-
phenylacetic acid;4FlPA, 4-fluorophenylacetic acid;BA, benzoic acid;4HBA, 4-hydroxybenzoic acid;HKP, 4-hydroxy-
2-ketopentanoic acid.B, E. coli ED1061AL (pPAL)was grown in LBmediumat anA600 of 0.8–1.0 in thepresenceof 1
mM 3HPP or PP. Results of one experiment are shown; valueswere reproducible in three separate experiments.
TABLE 1
Bacterial strains and plasmids with relevant genotype and phenotype
Strain or plasmid Relevant genotype and characteristic(s) Source or reference
Strain
S17-1pir Tpr Smr recA thi hsdRM RP4::2-Tc::Mu::Km Tn7 pir phage lysogen 13
M15 Strain for regulated high level expression with pQE vectors Qiagen
MC4100 F, araD319 
(argF-lac)U169 rpsL150(Smr) relA1 flbB5301 deoC1 ptsF25 rbsR 14
AFMC MC4100 spontaneous rifampicin-resistant mutant (Rifr) 15
AFMCRAL AFMC with chromosomal insertion mini-Tn5KmmhpR/Pa-lacZ 9
AFMCAL AFMC with chromosomal insertion mini-Tn5Km Pa-lacZ 9
MC1061 hsdR mcrB araD139 
(araABC-leu)7679 
lacX74 galU galK rpsL thi mhpRABCD 16
ED1061 MC1061 derivative with chromosomal insertion Km in hcaA1 8
ED1061AL ED1061 with chromosomal insertion mini-Tn5Sm/Sp Pa-lacZ This work
Plasmid
pUC18 Apr; oriColE1 high copy number cloning vector, lacZ 16
pPAL Apr, pUC18 derivative harboring themhpR gene 9
pSJ3 Apr; lacZ promoter probe vector, lacZ fusion flanked by NotI sites 17
pAL Apr; pSJ3 containing a 0.5-kilobase DNA fragment to produce themhpR/Pa-lacZ fusion 9
pRAL Apr; pSJ3 containing a 1.1-kilobase DNA fragment to produce themhpR/Pa-lacZ fusion 9
pJCD01 Apr; oriColE1, polylinker of pUC19 flanked by rpoC and rrnBT1T2 terminators 18
pJCDAR pJCD01 derivative containing Pr-Pa promoters This work
pREP4 kmr, plasmid that expresses the lacI repressor Qiagen
pQE32 Apr, oriColE1 T5 promoter lac operator,  to/E. coli rrnB T1 terminators, N-terminal His6 Qiagen
pQMH Apr, pQE32 derivative containing the His6-mhpR gene This work
pUT miniTn5 Sm/Sp Apr Smr; delivery plasmid for mini-Tn5 Sm/Sp 19
pUTAL-2 Apr Smr, pUTminiTn5 Sm/Sp containing the 4.4-kilobase NotI Pa-lacZ fragment from pAL This work
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the other inducermolecules, i.e. 3HCI, and to a lower degree by
DHPP (data not shown). These results suggest that PP does not
compete with the natural inducers for the effector binding site
at MhpR, but on the contrary, it produces a synergistic effect.
To assess whether the synergistic effect was PP dosage-depend-
ent, we measured the -galactosidase activity of E. coli
ED1061AL (pPAL) (Table 1) in the presence of 25M3HPP and
increasing amounts of PP. Fig. 3B shows that the PP synergistic
effect was indeed dosage-dependent, reaching the maximum
activation effect (15-fold) at 750 M PP.
MhpR-His Overexpression and Purification of MhpR-His—
To confirm the data obtained in vivo, we also characterized the
PP synergistic effect by in vitro studies. For this purpose we
cloned the genemhpR in the plasmid pQE32 to expressMhpR-
His, as described under “Experimental Procedures.” First, and
to test the functionality of the fusion MhpR-His regulator, the
strain of E. coli AFMCAL (Table 1) harboring plasmid pQMH,
expressingMhpR-His, andE. coliAFMCAL (pPAL), expressing
the wild typeMhpR regulator, were assayed for -galactosidase
activity. As expected, the levels of -galactosidase activity were
similar in both strains, suggesting that both proteins, MhpR
and MhpR-His, were equally functional (data not shown). The
MhpR-His protein was then expressed in E. coliM15 (Table 1)
and purified to homogeneity as described under “Experimental
Procedures.” The purification yield determined by densitomet-
ric scanning of SDS-PAGE gels was 85%. The purity and the
expected molecular mass of the purified monomer were con-
firmed by SDS/PAGE (Fig. 4A). Sedimentation velocity experi-
ments were carried out at different concentrations of MhpR in
the presence and in the absence of 3HPP, PP, or DHPP and
analyzed in terms of distribution of sedimentation coefficients,
allowing an evaluation of protein homogeneity and self-associ-
ation. Fig. 4B shows the sedimentation velocity data for a 15M
MhpR-His solution in the absence of 3HPP, demonstrating that
under these conditions MhpR sediments as a unique species
with an s value of 4.4 0.1 S, which is compatible with a glob-
ular protein dimer (according to SEDFIT and SEDNTERP cal-
culations). Because the c(s) distributions showed a single major
peak, c(s) values were transformed to amolar mass distribution
with SEDPHAT program, obtaining a molar mass value also
compatible with a protein dimer. The binding of effectors did
not alter the oligomeric state of the protein, as demonstrated by
sedimentation velocity studies of MhpR (15 M) performed in
the presence of 400 and 800 M 3HPP (data not shown).
Effect of 3HPP and PP on the in Vitro Binding of MhpR-His to
the mhpR-mhpA Intergenic Region—The effect of 3HPP and PP
on MhpR-His binding to its target DNA was tested in vitro by
electrophoretic mobility shift assay using the purified protein.
Data displayed in Fig. 4C, lane 1, show thatMhpR-His binds the
DNA probe (mhpR-mhpA intergenic region) in the absence of
any aromatic compound, with a Kd of 4.5  0.6 nM. The addi-
tion of PP or 3HPP to the reaction mix slightly decreased the
dissociation constant to a Kd of 2.1  0.2 and 1.7  0.3 nM,
respectively (Fig. 4, lanes 2 and 3). Furthermore, when both PP
and 3HPP were added together to the reaction mix (Fig. 4C,
lane 4), formation of the MhpR-His-DNA complex was
observed at even lower protein concentrations (Kd of 0.8 0.3
nM), supporting the synergistic effect observed in vivo.
The Synergistic Activation of MhpR by PP Was Observed in
Vitro—To study the functionality of MhpR-His as a transcrip-
tional activator we designed a single-round in vitro transcrip-
tion assay. We constructed plasmid pJCDAR that carries the
wholemhpR-mhpA intergenic region including both Pr and Pa
promoters (Fig. 1A). Although this template allowed us tomon-
itor transcription from Pa and Pr promoters, we focused our
analysis in the Pa promoter. As expected, no transcript band
was detected in the absence ofMhpR-His (data not shown), and
there was an absolute requirement for the inducers (3HPP or
DHPP) to detect the transcript band (Fig. 5A). The addition of
increasing concentrations of 3HPP (1–1000 M) significantly
increased transcription from the Pa promoter (Fig. 5A, lanes
1–6), and the same effect was observed in the presence of
DHPP (Fig. 5A, lanes 14–19). Interestingly, DHPP seems to be
a better inducer than 3HPP (Fig. 5B).
In agreement with the in vivo results, no transcript band was
detected in the presence of 1 mM PP (Fig. 5A, lane 7). However,
assays performed with MhpR-His and different proportions of
PP and either 3HPP or DHPP (Fig. 5A, lanes 8–13 and lanes
20–25, respectively) confirmed the synergistic effect of PP on
transcription from the Pa promoter, and the enhancement was
evenmore evidentwhenDHPP instead of 3HPPwas used as the
inducer molecule (Fig. 5B).
FIGURE 3. Synergistic effect of PP on the induction of mhp genes pro-
duced by 3HPP. A, E. coli ED1061AL (pPAL) was grown in LB medium in the
presence of increasing concentrations of 3HPP (1–1000 M) (black bar) or
combined with PP (1 mM) (gray bar) until the cultures reached an A600 of
0.8–1.0. Results of one experiment are shown; values were reproducible in
three separate experiments. B, concentration-dependent effect of PP on the
activation mediated by 3HPP. E. coli ED1061AL (pPAL) was grown in LB
medium in the presence of increasing concentrations of PP (1–1000 M)
(black bar) or combined with a non-saturating concentration of 25 M 3HPP
(gray bar). Results of one experiment are shown; values were reproducible in
three separate experiments.
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Changes in the MhpR-His Secondary Structure Induced by
3HPP and PP—To investigate the effect of 3HPP and PP on the
protein secondary structure, the far-UV CD spectrum of
MhpR-His was recorded in the absence and presence of 3HPP
and PP. The CD spectrum is characterized by two minima at
210 and 220 nm and a maximum around 200 nm, indicative of
-helix structure (data not shown). The overall secondary
structure composition of MhpR-His was estimated by decon-
volution of the CD spectrumusing three differentmethods (see
“Experimental Procedures”) which provided a consensus aver-
age of 36% (2%) -helices, 16.0% (0.6%) -strands, and 48%
(2%) turns and non-regular structures. The presence of 3HPP
induces a small but significant and reproducible decrease of the
dichroic signal at 210–224 nm, and the overall change could be
consistent with a slightly increase in the-helix content (4%).
Similar results were found by simultaneous addition of 3HPP
and PP. Variations induced by PP alone were slightly lower but
clearly indicated a direct interaction between PP and MhpR in
the absence of 3HPP. The stabilization of MhpR-His derived
from 3HPP or PP binding was ana-
lyzed by following the lost of sec-
ondary structure during thermal
denaturation in the absence and
presence of the ligands. Variations
in the CD signal were monitored at
220 nm from 5 to 90 °C (data not
shown). MhpR-His shows a single
transition between 30 and 55 °C
with a midpoint transition temper-
ature,T1⁄2, of 47.1 °C, suggesting that
MhpR-His denatures as a single
cooperative unit. The addition of 1
mM 3HPP increased the T1⁄2 by
7.0 °C, whereas the same concentra-
tion of PP produced an increase of
5.5 °C. Remarkably, the simultane-
ous addition of PP and 3HPP, 1 mM
each, did not result in a further sta-
bilization ofMhpR-His structure, as
the T1⁄2 was identical to the value
measured in the presence of 3HPP
alone. Thus, the stabilization in-
duced by the simultaneous presence
of both compounds does not seem
to be additive.
Spectrofluorometric Analyses of
the Interactions between MhpR-His
and Effectors—The interactions of
MhpR-His with their cognate effec-
tors were studied by fluorescence
spectroscopy, a technique that de-
tects local environmental changes
in protein aromatic residues (30).
MhpR has four tryptophan residues
at positions 88, 106, 152, and 204.
Residue Trp-88 is located adjacent
to the linker region between the N-
and C-terminal domains, whereas
residues Trp-106, Trp-152, and Trp-204 are located within the
C-terminal effector binding domain of MhpR-His (31). The
addition of the inducers 3HPP and DHPP caused a significant
concentration-dependent quenching of the fluorescence emis-
sion spectrum (Fig. 6, B and C, respectively; note as well a
5-nm blue-shift in the emission maximum with DHPP). PP
also quenched the protein fluorescence in a concentration-de-
pendentmanner, corroborating its direct binding toMhpR-His
inferred from CD experiments. In contrast, the decrease of the
fluorescence intensity observed upon the addition of the non-
inducer 3HPA (a 3HPP structural analog employed as a nega-
tive control) was very small (Fig. 6A), which suggests that the
quenching effects caused by 3HPP, DHPP, and PP are highly
specific.
Fluorescence titration data (Fig. 7) were analyzed assuming a
single set of binding sites (“Experimental Procedures”) to cal-
culate the affinity constants and the maximum quenching of
the three effectors. The best-fitting data yielded similar values
for the dissociation constants: 29 1 M for 3HPP, 24 2 M
FIGURE 4. A, overexpression and purification of MhpR-His protein. Analysis on a 12.5% SDS-PAGE of the puri-
fication of MhpR-His from E. coliM15 (pREP4, pQMH) cells. Lane 1, molecular mass markers shown in kDa; lane
2, soluble fraction of the crude extract from E. coli M15 (pREP4, pQMH); lane 3, extract that flows through the
nickel-nitrilotriacetic acid-agarose column; lane 4, washing step; lane 5, purifiedMhpR-His protein loadedat 1.5
mg/ml. B, distribution of the sedimentation coefficients for the MhpR-His protein. c(s) sedimentation coeffi-
cient distribution was at a protein concentration of 0.5 mg/ml, a rotor temperature of 20 °C, and a rotor speed
200,000  g. C, gel retardation analyses of MhpR-His binding to the Pa-Pr promoter in absence of aromatic
compound. Increasing concentrations of purified MhpR-His were used: lane 1 (0 nM), lane 2 (0.5 nM), lane 3 (1
nM), lane 4 (2.5 nM), lane 5 (5 nM), lane 6 (7.5 nM), lane 7 (10 nM), lane 8 (20 nM), lane 9 (40 nM), and lane 10 (80 nM).
Pa-Pr concentration was 1 nM. D, determination of the Kdfor MhpR-His binding to the mhpR-mhpA intergenic
region in the absence (closed circles) and presence of 0.5mM PP (open circles), 0.5mM 3HPP (closed triangles), or
at 0.25mM both compound (open triangles). The Kdwas theMhpR-His concentration at which 50% of the total
probe was bound. This value was determined from the curves. The concentration of the probe is significantly
lower than the MhpR-His concentration. Errors bars are S.D.
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for DHPP, and 30  1 M for PP, whereas the relative fluores-
cence under saturating conditions (Fmin) of PP (0.76 0.03) was
higher than for 3HPP (0.60 0.03) and DHPP (0.59 0.02). The
related compound 3HPA, used as the negative control, showed a
very weak fluorescence decrease and a higher dissociation con-
stant (0.1 M). Fluorescence studies also allowed us to further
investigate the effect of PP on MhpR binding to its natural effec-
tors. When 3HPP or DHPP were added simultaneously with PP,
the fluorescence intensity of the protein decreased more than
when 3HPP or DHPPwas added alone (Fig. 6, E and F). The fluo-
rescence decrease caused by the separate addition of 100 M
3HPP, PP, or DHPP was compared in Fig. 6G with the decrease
providedby the sequential additionofPPand3HPPorDHPP (100
M each). In contrast, DHPP addition toMhpR samples contain-
ing saturating concentrations of 3HPP does not modify the
quenched emission spectra (data not shown). These results alto-
gether are consistentwith thenotion thatDHPPand3HPPbind to
the samesite(s),whereasPPhas adifferentbinding locus inMhpR,
as can also be concluded from theTm for HhpR in the presence of
either or both ligands.
DISCUSSION
The MhpR activator belongs to the IclR family of tran-
scriptional regulators. The characterized members of this
family are involved in the regulation of diverse catabolic
pathways ranging from the degra-
dation of plant cell polysacchar-
ides in the plant pathogen Erwinia
sp (32, 33) to the metabolism of
aromatic compounds in E. coli,
Acinetobacter, and Pseudomonas
(34–39). IclR family members typi-
cally have anN-terminal helix-turn-
helix DNA binding motif followed
by the C-terminal domain adapted
to recognize a wide variety of small
cellular metabolites as effectors.
Sequence analysis of IclR regulators
revealed a low conservation of the
amino acid residues involved in
effector binding. This reflects the
large chemical diversity of inducer
molecules recognized by members
of this family showing the extraordi-
nary structural evolutionary flexi-
bility of these proteins. However, it
should be notice that each regulator
is able to bind highly specifically
only a small number of effectors as
shown by MhpR. In fact the in vivo
analysis of the potential effectors of
MhpR here performed showed that,
among all the compounds tested,
only the substrates of themhp path-
way (3HPP, 3HCI) and the first
intermediate (DHPP) were efficient
inducers of the regulator, as 2-hy-
droxyphenylpropionic acid only
produced a very weak induction (Fig. 2A). Very closely related
compounds having other substitutions either in the aromatic
ring or the lateral chain did not activate the MhpR regulator.
This agrees with the narrow effector specificity displayed by
other members of the IclR family, with the unique exception of
the TtgV regulator, which recognizes a wide range of structur-
ally different effectors (40). The aromatic compounds were
tested at 1 mM, as it is generally assumed that at this concentra-
tion these molecules can diffuse across biological membranes,
making transport theoretically unnecessary (14, 41–45). Nev-
ertheless, we cannot rule out that the absence of induction
could be because of the inability of these compounds to enter
the cell.
Within the IclR family only a small number of compounds
have been formally identified as effectors so far (12, 34, 40, 44,
46–49).Moreover, the regulatorymechanism of these proteins
and the structure of the effector binding domain in the free and
the effector-bound states have been poorly characterized so far,
with the sole exceptions of the regulator AllR and the model
system IclR (12, 47).
Previous studies performed using crude cellular extracts
showed that MhpR is a regulatory protein that binds to the Pa
promoter at position58 from the transcription initiation site (9).
It was also demonstrated by gel retardation assays that theMhpR
binding from crude extracts to themhpR-mhpA intergenic region
FIGURE 5. Effect of 3HPP andDHPPon the transcriptional activation from Papromotermediated byMhpR-
His.A, single round in vitro transcriptionwas carried out by using the plasmid pJCDAR as template. The concentra-
tionsofproteinswere100nMRNAp, 100nMMhpR-His, and200nMCRP. Lanes 1–6 contained1, 10, 50, 100, 500, and
1000M3HPP, respectively.Lane7contained1mMPP.Lanes8–13containedthesamegradientbut in thepresence
of 1mMPP. Lanes 14–19 contained 1, 10, 50, 100, 500, and 1000MDHPP, respectively. Lanes 20–25 contained the
samegradient but in presence of 1mMPP.Arrowspoint to the Pa-derivedmRNA (181 nucleotides) and the vector-
derived RNA1 (108–109 nucleotides). B, Pa transcription levels (in arbitrary units) produced frompJCDAR template
in the presence of 1–1000M 3HPP or DHPP in the absence and presence of 1mMPP.
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was improved in the presence of
3HPP, although it was not essential
(9). The binding studies here per-
formed by electrophoretic mobility
shift assay with the purified MhpR-
His protein indicate that 3HPP
improved the retardation of the
DNA probe, although MhpR-His
alone can efficiently bind to the Pa
promoter in vitro. These results rule
out the possibility that the binding
effect previously observed could be
because of the presence of a 3HPP-
like effector in crude cell extracts.
Therefore, our current results dem-
onstrate that MhpR recognizes the
Pa operator sequence even in the
absence of the effector. However, in
vivo assays (9) and in vitro transcrip-
tion experiments showed that initi-
ation of transcription from Pa pro-
moter is only achieved in the
presence of the effectors molecules
3HPP or DHPP (Fig. 5, lanes 1–6
and lanes 14–19, respectively). Sev-
eral IclR regulators involved in aro-
matic catabolic pathways bindDNA
in the absence of their effector mol-
ecules (35, 37, 51, 52). Although no
explanation has been put forward so
far to account for this phenomenon,
it could be hypothesized that these
regulators could acquire a confor-
mation that allows them to recog-
nize and interact with the operator
region DNA, but only in the pres-
ence of effectors might they pro-
mote formation of the closed com-
plex between RNAp and the core
promoter, which favors contacts
with the non-consensus35 boxes,
as occurs in the case of the Pa
promoter.
Analytical ultracentrifugation ex-
periments showed that MhpR-His
sediments (in the absence and in the
presence of 3HPP) as a single species
with an s value compatiblewith apro-
tein dimer. The founding member of
the family, IclR, is in a dynamic equi-
librium between the dimeric and tet-
rameric states in solution and binds
its operator as a tetramer (53, 54).
TM-IclR fromThermotogamaritima
is a dimer in solution, but it was pro-
posed to bind as a dimer of dimers to
its cognate operator (55). Other IclR
members such as Pir from Erwinia
FIGURE 6. Quenching of intrinsic fluorescence of MhpR-His by different ligands. Fluorescence emis-
sion spectra of MhpR-His (0.5 M) in the presence of increasing concentrations (from 10 to 100 M) of
3HPA, used as negative control (A), 3HPP (B), DHPP (C), PP (D), 3HPP and PP (E), and DHPP and PP (F). The
solid and dotted curves represent the spectra recorded in the absence and presence of increasing concen-
trations of ligand, respectively. The arrows show the decrease of the fluorescence. G, comparison of the
fluorescence decrease caused by the addition of 3HPP, PP, or DHPP in excess (100 M) with the decrease
provided by the previous addition of PP at saturating concentration (100M) and the posterior addition of
3HPP or DHPP.
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chrysanthemi and PcaR and PcaU both from Acinetobacter sp.
ADP1 were shown to be dimers in solution (37, 48, 56). However,
TtgV is a tetramer in solution both in the presence and absence of
effectors and also in its DNA-bound state (57). The addition of
ligand drastically increased AllR tetramerization, whereas three
species (monomer, dimer, and tetramer)weredetected in solution
in the absence of effectors (47). Nevertheless, very few data have
been reported so far about the interactionsof these regulatorswith
aromatic effectors or synergistic regulatory mechanisms. In this
sense, the synergistic effect of PP,which is not aMhpReffector, on
transcriptional activation by 3HPP or 3HCI is surprising. More-
over, this effect depends on the PP concentration, showing maxi-
mum activation at 750 M in our experimental conditions (Fig.
3B). A similar, but not identical, synergistic response has been
described for the BenM regulator, belonging to the LysR family
from Acinetobacter sp. strain ADP1, which responds to two
metabolites, benzoate and cis,cis-muconate. In this particular case
both effectors are true inducers, being as cis,cis-muconate ismore
effective than benzoate as the sole co-activator (10, 11). On the
other hand, it has been described that two different metabolites,
glyoxylate and pyruvate, are able to bind to the IclR regulator and
show opposite effects. Glyoxylate disrupted the formation of the
IclR/operator complexby favoring thedimeric stateof theprotein,
whereas pyruvate increased the binding of the IclR to the target
promoter by stabilizing the active tetrameric form of the protein
(12).
In this work we have demonstrated for the first time that two
compounds metabolized by different degradation pathways,
3HPP and PP, act synergistically to activate gene expression of
the mhp operon through a sole regulatory protein. By electro-
phoreticmobility shift assaywe have confirmed thatMhpR-His
binds its operator more efficiently when 3HPP and PP are pres-
ent, as the Kd decreased 2-fold (Fig. 4C, lanes 2–4). In vitro
transcription assays have shown that the level of transcription
regulated by MhpR-His in response to both compounds was
significantly higher than the sum of the effects because of each
compound alone. This synergistic response was more efficient
when DHPP instead of 3HPP was used as inducer (Fig. 5,A and
B). The in vitro transcription experiments also suggest that
DHPP is amore efficient inducer than 3HPP (Fig. 5). This result
agrees with the hypothesis that during the catabolism of PP, the
mhp pathway must be induced very quickly by low concentra-
tions of DHPP to avoid the accumulation of this catecholic
compound, which could became toxic for the cell (58). Never-
theless, this result does not appear to agree with the data
obtained in vivo in which the PP synergistic effect was not
observed in the presence of 1 mM DHPP (data not shown).
However, a plausible explanation for this observation is that
DHPP, as occurs with other catecholic compounds, might not
enter into the cells in vivo as efficiently as 3HPP or 3HCI (6).
It is well known that ligand binding stabilizes protein struc-
tures, and thus, the analytical techniques that measure protein
thermostability can be used to study protein-ligand interac-
tions (50, 59–61). The transition temperature of MhpR is
increased by 7 and 5.5 °C in the presence of 1 mM 3HPP or PP,
respectively. However, the simultaneous addition of 3HPP and
PP did not produce any additional increase of theT1⁄2, indicating
that the presence of both effectors does not results in a further
stabilizing of MhpR structure. In the case of the C-terminal
domains of AllR and IclR regulators from E. coli, glyoxylate was
identified as the strongest thermo-stabilizing inducer (12). The
binding of 3HPP, DHPP, and PP to MhpR-His was character-
ized using fluorescence spectroscopy formonitoring changes in
the environment of MhpR tryptophan residues. We also
observed that the addition of 3HPP or DHPP to MhpR-His
previously saturated with PP induced a further quenching of
the fluorescence (Fig. 7), suggesting that the binding site of PP is
different from that/those shared byDHPP and 3HPP. In related
proteins, the structure of the BenM effector binding domain
revealed two different binding sites for benzoate and cis,cis-
muconate (11), whereas the IclR crystal structure has con-
firmed the binding of pyruvate and glyoxylate to a single effec-
tor recognition site (12).
The in vitro studies demonstrated thatMhpR-His is the pro-
tein responsible for the dual compound response. The simulta-
neous binding of PP and 3HPP/DHPPmay alter the conforma-
tion of MhpR-His in a way that significantly changes the
regulator-DNA and/or regulator-polymerase interaction acti-
vating Pa transcription. Therefore, in the presence of both
compounds MhpR-His would achieve a unique conformation
that favors a higher level of transcription.
The physiological role of PP as aMhpR-His synergic effector
can be explained by the convergence of PP and 3HPP catabolic
pathways. As shown in Fig. 1B, cells need to activate the mhp
pathway to catabolize PP, and such activation is produced as
long as DHPP is synthesized. As mentioned above, this can
explain why DHPP behaves in vitro as a better inductor than
3HPP, as DHPP should not be accumulated because, like other
catechols, it could be highly toxic for the cells (58) and has to be
cleaved as quickly as possible. Then, immediately after DHPP
begins to be accumulated, the synergismbetweenPP andDHPP
on MhpR-mediated activation favors a rapid expression of the
mhp genes, and the subsequent synthesis of the MhpB dioxy-
genase should reduce its toxic effect.
Summarizing, our data reinforce the preliminary assumption
that the Pa promoter of the mhp pathway and its MhpR regu-
FIGURE 7. Quenching of MhpR-His (0.5 M) tryptophan fluorescence as a
functionof ligandconcentrationatpH7.5.Datapoints represent thedecrease
at the emission maximum in the presence of 3HPA used as a negative control
(opendiamonds), PP (open squares), 3HPP (open circles), andDHPP (closed circles).
The curves through the data points were generated using Equation 1.
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lator represent an illustrative example of the great complexity
achieved by certain bacterial regulatory systems. Such com-
plexity is required to precisely control the expression of a key
enzyme in two convergent metabolic pathways using two sub-
strates, 3HPP and PP, which generate the same intermediate
DHPP. This tightly regulated systemuses two transcription fac-
tors for its activation, MhpR and CRP, and maximizes the effi-
ciency of activation by using two synergistic effectors for the
same transcription factor.
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